HYPD
NASDAQ · Pharmaceuticals
Hyperion Defi Inc
$3.27
-0.37 (-10.16%)
Open$3.59
Previous Close$3.64
Day High$3.70
Day Low$3.25
52W High$17.18
52W Low$0.85
Volume—
Avg Volume474.9K
Market Cap26.72M
P/E Ratio—
EPS$-17.80
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+393.6% upside
Current
$3.27
$3.27
Target
$16.14
$16.14
$9.68
$16.14 avg
$20.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 515.0K | 3.22M | 5.01M |
| Net Income | -447,700,612 | -2,518,315,942 | 1.46M |
| Profit Margin | -86,882.5% | -82,538.4% | 29.2% |
| EBITDA | -428,666,262 | -2,545,205,930 | 1.99M |
| Free Cash Flow | — | — | 1.60M |
| Rev Growth | -84.0% | -84.0% | +22.0% |
| Debt/Equity | 1.59 | 1.59 | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |